Client Growth:
Client growth has been very impressive over the past 4 years since listing on the ASX. As the biggest player, they are now in the box seat to continue adding more blue chip clients to their platform in an exponential fashion, leveraging their reputation and historical investments in technology to build a best in class solution.
Moreover, XF1 clients are highly distributed across a variety of regions and sectors, which provides diversification and revenue protection. Professional services is the largest sector (clients include KPMG and EY), followed by recruitment, healthcare and Government/Defence. Clients include food and beverage company Lion, general and life insurer Zurich Australia, media groups Seven West Media and News Corporation, recruiting experts Hays, telecommunication firms Optus and Macquarie Telecom and companies including Hitachi Australia, Queensland Health, Inghams and Viva Energy
I like the very large number of positive client testimonials. As an investor this is very important. It is clear that XREF is supported by the strong endorsement of their clients who benefit from greater user friendliness and significant time and cost savings. I have also reached out to a friend who has used the platform when acting as a referee who has provided positive feedback about the XREF platform.
Worth checking out: https://www.xf1.com/ & https://www.xref.com/company/customer-stories
T.E.P.
- Forums
- ASX - By Stock
- XF1
- Why I am Buying XF1 (XREF)
Why I am Buying XF1 (XREF), page-4
-
- There are more pages in this discussion • 67 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add XF1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
13.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $25.52M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 9668 | 13.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
17.0¢ | 40000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 9668 | 0.135 |
1 | 100000 | 0.130 |
1 | 19800 | 0.125 |
2 | 91658 | 0.120 |
1 | 9095 | 0.110 |
Price($) | Vol. | No. |
---|---|---|
0.170 | 40000 | 1 |
0.180 | 47000 | 2 |
0.190 | 24375 | 1 |
0.200 | 51850 | 4 |
0.000 | 0 | 0 |
Last trade - 16.12pm 10/10/2024 (20 minute delay) ? |
Featured News
XF1 (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online